Fuji Keizai Group expects 2013 Japanese market for tissue engineering to reach 55.1 billion Yen , 6.9 % increase in two years
Fuji Keizai Co., a Tokyo-based market analyst, has included six categories in her report: bio devices, biomaterials, cells, cell culture and storage services, instruments for cell culture, and cell culture equipment Fuji Keizai Co. press release, July 31, 2012 (Japanese)